Skip to main content

Peer Review reports

From: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

Original Submission
23 Mar 2018 Submitted Original manuscript
10 Jan 2019 Author responded Author comments - Grazia Daniela Femminella
19 Nov 2018 Reviewed Reviewer Report - Larissa Aguiar
25 Nov 2018 Reviewed Reviewer Report - Felipe Castañeda
Resubmission - Version 2
10 Jan 2019 Submitted Manuscript version 2
23 Jan 2019 Author responded Author comments - Grazia Daniela Femminella
13 Jan 2019 Reviewed Reviewer Report - Felipe Castañeda
Resubmission - Version 3
23 Jan 2019 Submitted Manuscript version 3
Publishing
27 Feb 2019 Editorially accepted
3 Apr 2019 Article published 10.1186/s13063-019-3259-x

You can find further information about peer review here.

Back to article page